-
Mashup Score: 6
After much buzz, the entry of Humira biosimilars is awaited as a cost-cutting opportunity, but market penetration will likely not be instant.
Source: Pharmaceutical TechnologyCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
We explore the remote monitoring tech developed in Scotland to improve delivery of healthcare services, vital for an ageing population.
Source: Pharmaceutical TechnologyCategories: Healthcare Professionals, Latest HeadlinesTweet-
How remote monitoring #RPM tech is enhancing #healthcare for #aging populations - A growing ageing population presents many challenges for health services globally that are already buckling under the strain of recovering | #Scotland #NHS #UK #seniorcare https://t.co/V4sVqvTLWh
-
-
Mashup Score: 9Robotics innovation: Leading companies in microneedles for transdermal drug delivery - 1 year(s) ago
GlobalData uncovers the leading innovators in microneedles for transdermal drug delivery for the pharmaceutical industry.
Source: Pharmaceutical TechnologyCategories: Future of Medicine, Latest HeadlinesTweet-
Robotics innovation: Leading companies in microneedles for transdermal drug delivery https://t.co/w6y1zgMuN1 https://t.co/OinCOAmOCx
-
-
Mashup Score: 0
Many companies in the healthcare industry are expected to prioritise AI as their main investment target over the next two years.
Source: Pharmaceutical TechnologyCategories: Future of Medicine, Latest HeadlinesTweet-
AI will continue to attract investment in near future in the healthcare industry https://t.co/GhkbGrONig https://t.co/RkQKQuGNwx
-
-
Mashup Score: 0Inside the European mass shift to data-driven health solutions - 2 year(s) ago
European countries embrace electronic health records (EHRs) to improve healthcare as funding and innovation accelerate in the field.
Source: Pharmaceutical TechnologyCategories: Healthcare Professionals, Latest HeadlinesTweet-
Inside the #Europe mass shift to #data-driven #healthcare solutions - European countries embrace #EHRs to improve healthcare as funding & #innovation accelerate in the field https://t.co/WNq12yEQYu
-
-
Mashup Score: 0
Novo Nordisk has signed a new strategic partnership with Microsoft to expedite the discovery and development of drugs using big data and AI.
Source: Pharmaceutical TechnologyCategories: Future of Medicine, Latest HeadlinesTweet-
Again, a pharma company working together with a tech giant. @novonordisk signed a strategic partnership with @Microsoft to expedite the discovery and development of drugs leveraging big data and artificial intelligence. https://t.co/Wd0DlhPDrP
-
-
Mashup Score: 1
Presentations at the ESMO Congress 2022 have demonstrated the critical importance of therapy sequence for locally advanced cancer.
Source: Pharmaceutical TechnologyCategories: Hem/Oncs, Latest HeadlinesTweet-
Thank you for using so many direct quotes from my presentation - word for word, just missing the “ “ #ESMO22: neoadjuvant or adjuvant immunotherapy for locally advanced cancers? https://t.co/Ajnps8QrM3 via @PharmaTechFocus
-
-
Mashup Score: 0Why aren’t digital pills taking off? - 2 year(s) ago
While digital pills offer a chance to improve adherence, their use in vulnerable populations remains rife with challenges.
Source: Pharmaceutical TechnologyCategories: Future of Medicine, Latest HeadlinesTweet-
Why aren’t digital pills taking off? - Pharmaceutical Technology https://t.co/RChumljAos https://t.co/5ZQCehdqqz
-
-
Mashup Score: 2NICE makeover: a new look for the UK's HTAs - 2 year(s) ago
UK health technology assessments (HTA)s enter a new era following changes from the National Institute for Health and Care Excellence (NICE) and diversion from EU standards
Source: Pharmaceutical TechnologyCategories: Healthcare Professionals, Latest HeadlinesTweet-
#NICE makeover: a new look for the #UK’s #HTAs - UK health technology assessments (HTA)s enter a new era following changes from the National Institute for Health and Care Excellence (NICE) and diversion from #EU standards. | #digitalhealth https://t.co/33HwFJWPiN
-
-
Mashup Score: 41Insulin pricing: could an e-commerce approach cut costs? - 2 year(s) ago
An e-commerce drug delivery approach could put a dent in upward spiraling insulin prices, but uptake challenges loom large.
Source: Pharmaceutical TechnologyCategories: Hem/Oncs, Latest HeadlinesTweet-
This is not price increase for a newer more fancy and luxurious car over time. It's price increases of exact same insulin over time in the US. #Insulin4all https://t.co/6kHKs9waQY https://t.co/895h8nWETs
-
Humira biosimilars became available in EU 10/18; and will soon be available in the USA w/ Amjevita (Amgen) available Jan 2023 & 6 others (Pfizer, BI, Samsung, Coherus, Sandoz, Biocon) after July 2023. https://t.co/LH3MpT0o9O https://t.co/VeCbcdq5Ie